Research facility · founded 1983
Beckman Research Institute
- Citations, last 5 years
- 43.4k
- Works, last 5 years
- 2 597
- h-index
- 528
- Scientists listed
- 0
- Grants since 2016
- 719
Grants received
2023–2026 · research · R01
Role of trefoil factor family proteins in beta cell function.
Patrick T. Fueger · Beckman Research Institute · funded by National Institutes of Health
2023–2025 · research · R37
Combinational Targeting the Feed-forward Epigenetic Circuitry in Mixed Lineage Leukemia
Chun-Wei David Chen · Beckman Research Institute · funded by National Institutes of Health
2023–2026 · research · R01
A Novel Bone Marrow Transplantation Approach for Sickle Cell Disease Using Targeted Marrow Irradiation
Susanta K Hui · Beckman Research Institute · funded by National Institutes of Health
2023–2030 · research · R35
The role of the intestinal microbiome in cancer immunotherapy
Marcel R M Van Den Brink · Beckman Research Institute · funded by National Institutes of Health
2023–2027 · research · R01
Pathogenesis, prevention and treatment of corticosteroid-resistant gut GVHD
Defu Zeng · Beckman Research Institute · funded by National Institutes of Health
2023–2028 · research · R37
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
Srividya Swaminathan · Beckman Research Institute · funded by National Institutes of Health
2023–2027 · research · R01
Circadian clock and temporal control in nutrient metabolism
Ke Ma · Beckman Research Institute · funded by National Institutes of Health
2023–2028 · research · R01
Okazaki fragment maturation: mutagenesis and cell survival
Binghui Shen · Beckman Research Institute · funded by National Institutes of Health
2023–2028 · research · R01
Advancing Photoacoustic Tomography in breast imaging to predict response in breast cancers treated with neoadjuvant therapy
Lily Lau Lai · Beckman Research Institute · funded by National Institutes of Health
2023–2028 · research · R01
TET2-mediated epitranscriptomic regulation in leukemia microenvironment
Jianjun Chen · Beckman Research Institute · funded by National Institutes of Health
2023–2025 · research · R01
Define the oncogenic role of METTL3 in the pathogenesis of chronic lymphocytic leukemia
Lili Wang · Beckman Research Institute · funded by National Institutes of Health
2023–2028 · research · R01
Targeted radiation and immunocytokine therapy for CEA positive malignancies
John Ernest Shively · Beckman Research Institute · funded by National Institutes of Health
2023–2028 · research · R01
Myeloid cell-selective, oligonucleotide-based STAT3 inhibition combined with total marrow and lymphoid irradiation for immunotherapy of acute myeloid leukemia
Susanta K Hui · Beckman Research Institute · funded by National Institutes of Health
2023–2026 · research · R01
Role of trefoil factor family proteins in beta cell function.
Patrick T. Fueger · Beckman Research Institute · funded by National Institutes of Health
2023–2028 · research · R01
Targeting the Microenvironment/Oncogene Cooperation to treat poor prognosis T-ALL
Nadia Carlesso · Beckman Research Institute · funded by National Institutes of Health
2023–2029 · research · R01
Elucidating the Cellular Origins of lung adenocarcinoma
Crystal Nicole Marconett · Beckman Research Institute · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Administrative Core
Victoria L. Seewaldt · Beckman Research Institute · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Core 1: Planning and Evaluation
David K. Ann · Beckman Research Institute · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Project 2
Mustafa Raoof · Beckman Research Institute · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Core 3: Outreach
Christopher M. Sistrunk · Beckman Research Institute · funded by National Institutes of Health
2022–2026 · research · R01
Role of de novo pyrimidine biosynthesis in pathological cardiac remodeling
Zhao Wang · Beckman Research Institute · funded by National Institutes of Health
2022–2026 · research · R01
Extracellular Vesicle-mediated islet immune cross talk in Type 1 Diabetes pathogenesis
Sally Choate Kent · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
A Phase 1 Study to Evaluate Chimeric Antigen Receptor (CAR) T cells Targeting TAG72 in Patients with Recurrent Epithelial Ovarian Cancer
Saul Priceman · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
Stephen J Forman · Beckman Research Institute · funded by National Institutes of Health
2022–2024 · research · R21
Anti-CD25 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Leukemia
Jeffrey Y Wong · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
BAFF-R CAR T cell therapy for ALL
Ibrahim Aldoss · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · grant · DP5
Biomarkers, mechanisms and modulation of oxidative stress associated risk factors in carcinogenesis
Yun Rose Li · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
Development of Microbial-Based Therapies to Suppress Macropinocytosis in Kras-Driven Cancers
Edwin Manuel · Beckman Research Institute · funded by National Institutes of Health
2022–2024 · fellowship · F99
Targeting a Novel Pocket on ITGAV
Nicole Mattson · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
Leveraging Digital Health Solutions to Reduce Learning and Functional Disparities in Children with Cancer - Diversity Supplement
Sunita K Patel · Beckman Research Institute · funded by National Institutes of Health
2022–2024 · research · R01
Phase 1 Evaluation of Enhanced Natural Killer Cells as a Treatment Strategy in Non-Small cell Lung Cancer Patients Refractory to PD-1/PD-L1 Immune Checkpoint Inhibitors
Miguel A Villalona · Beckman Research Institute · funded by National Institutes of Health
2022–2025 · research · RF1
Define the effect of CLU SNP on the risk to Alzheimer's disease
Yanhong Shi · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
A Phase 1 Study to Evaluate Chimeric Antigen Receptor (CAR) T cells Targeting TAG72 in Patients with Recurrent Epithelial Ovarian Cancer
Saul Priceman · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
A Phase 1 Study to Evaluate Chimeric Antigen Receptor (CAR) T cells Targeting TAG72 in Patients with Recurrent Epithelial Ovarian Cancer
Saul Priceman · Beckman Research Institute · funded by National Institutes of Health
2022–2023 · fellowship · Postdoctoral Fellowship
Integrated stress response protects against ischemic heart disease by antagonizing oxidative stress
Guangyu Zhang · Beckman Research Institute · funded by American Heart Association
2022–2023 · fellowship · Postdoctoral Fellowship
PAK1 SIGNALING: POTENTIAL TARGETING IN DIABETES WITH IMPROVED CARDIOVASCULAR OUTCOMES
Rekha Balakrishnan · Beckman Research Institute · funded by American Heart Association
2022–2025 · research · R03
Determinants of Repeat Colorectal Cancer Screening in a Safety-Net System
Narissa Jennifer Nonzee · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
Stephen J Forman · Beckman Research Institute · funded by National Institutes of Health
2022–2024 · research · R03
Determinants of Repeat Colorectal Cancer Screening in a Safety-Net System
Narissa Jennifer Nonzee · Beckman Research Institute · funded by National Institutes of Health
2022–2024 · career development · K99
Immune Evasion Mechanisms of KSHV Complement and Fc-Receptor Proteins
Murali Bagalur Muniraju · Beckman Research Institute · funded by National Institutes of Health